Toronto, ON – CANADA: January 22, 2015
FYi Doctors is pleased to announce their recent purchase of CIRRUS™ HD-OCTs - the industry-leading device in OCT[i] from ZEISS. With over 160 years of innovation and as the creator of the OCT technology, ZEISS has over 10,000 OCTs in the market. ZEISS strives to serve doctors with complete solutions to support better workflows.
“For many years we have been a trusted partner for the eye care specialist looking for advanced diagnosis and treatment devices offering them complete solutions for optimal workflows to enhance patient care. We are pleased FYi Doctors has chosen ZEISS as a trusted partner for OCTs”, said Moosah Gulam, Vice President of the Medical Division at Carl Zeiss Canada.
The ZEISS CIRRUS HD-OCT offers tools to aid in the management of glaucoma, retinal disease and anterior segment imaging for corneal disease. CIRRUS HD-OCT will revolutionize early detection of common eye conditions and help FYi Doctors manage disease.
Dr. Alan Ulsifer, CEO and President of FYidoctors added, “Commitment to eye care and technology is simply part of who we are. This purchase is just part of our ongoing dedication to our patient’s well-being, but also a big part of our brand.”
For over 160 years ZEISS has been involved in the development of high performance optical devices and has a leading and extensive portfolio in eye care. ZEISS offers diagnostic solutions for all the major eye disease clusters – glaucoma, retina, refractive and cataract. With many years of experience in producing cutting-edge diagnostic technology, ZEISS is an ideal partner for the optometric practitioner looking to differentiate and provide the highest level of patient care.
ZEISS is pleased to offer a complete solution for optometry, with the CIRRUS HD-OCT, multiple field analyzers, including the gold standard Humphrey Field Analyzer for perimetry, VISUCAM and CIRRUSphoto for fundus imaging, all tied together by FORUM eye care data management system. Furthermore, ZEISS can now provide its customers with a more comprehensive offering for basic ophthalmic diagnostics than ever before. The Essential Line provides all eye specialists with access to ZEISS quality from the start and includes not only the proven slit lamps with imaging functions, but also products for objective and subjective refraction, examinations of the retina and measurement of intraocular pressure.
By bringing the CIRRUS technology into its offices, together FYi Doctors and ZEISS are working together to improve and advance patient care.
[i] Retinal Diagnostic Devices Report, Market Scope, 2013.
About ZEISS
Carl Zeiss Meditec AG is one of the world’s leading medical technology companies. The company supplies innovative technologies and application-oriented solutions designed to help doctors improve the quality of life of their patients. It provides complete packages of solutions for the diagnosis and treatment of eye diseases, including implants and consumables. The company creates innovative visualization solutions in the field of microsurgery. The medical technology portfolio of Carl Zeiss Meditec is rounded off by promising, future-oriented technologies such as intraoperative radiotherapy.
Carl Zeiss Vision is one of the world's leading manufacturers combining ophthalmic expertise and solutions with an international brand. The business group develops and produces instruments and offerings for the entire eyeglass value chain.
About FYidoctors
FYidoctors is a private, optometry-owned, eye care company with its home office located in Calgary, Alberta and a fully automated, freeform laboratory and distribution facility located in Burnaby, British Columbia and Quebec, QC. FYidoctors is currently one of Canada’s largest providers of ophthalmic products and services with over 450 optometrists servicing over 280 locations between its corporately owned locations and Vision Source Canada locations. FYidoctors also has Canadian distribution rights to multiple optical and vision products. To learn more please visit www.fyidoctors.com.